Neurotrophic Keratopathy Studies
Neurotrophic Keratopathy
Not Applicable (Service Provider)Active
Key Facts
Indication
Neurotrophic Keratopathy
Phase
Not Applicable (Service Provider)
Status
Active
Company
About Oculus Research
Oculus Research is a private, US-based clinical research organization founded in 2014, operating as a site management organization (SMO) that conducts trials for external sponsors. The company has a strong track record in ophthalmology, having contributed to the development and FDA approval of nine treatments, including TYRVAYA, VEVYE, and MIEBO. Its business model is service-based, generating revenue from sponsors and CROs for patient recruitment and trial execution across a diverse range of therapeutic areas beyond eye care, such as vaccines, diabetes, and mental health.
View full company profile